Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02612090 · ClinicalTrials.gov registry record · NA

The Cholesterol Lowering Effects of Strawberry

A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT02612090 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 46 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02612090, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

Primary objective is to assess strawberry intake on LDL cholesterol and its association with atherosclerosis development.

Interventions

  • DIETARY_SUPPLEMENT Active Treatment Beverage
  • DIETARY_SUPPLEMENT Placebo Treatment Beverage

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2016-01-04
Est. Completion 2018-10-31
Phase NA

What the Registry Record Tells You About NCT02612090

The ClinicalTrials.gov registry entry for NCT02612090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Active Treatment Beverage is the first listed.

NCT02612090 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02612090 about?

NCT02612090 is a clinical study titled "The Cholesterol Lowering Effects of Strawberry". Primary objective is to assess strawberry intake on LDL cholesterol and its association with atherosclerosis development.

What is the current status of trial NCT02612090?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2016-01-04. Estimated completion is 2018-10-31.

What interventions are being tested in trial NCT02612090?

The interventions under investigation include: Active Treatment Beverage (DIETARY_SUPPLEMENT), Placebo Treatment Beverage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02612090?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.